VOLUME 68   2007   NUMBER 5

Editorial

653 Call for Papers From Early Career Psychiatrists. Marlene P. Freeman and Alan J. Gelenberg
[PDF]

Original Articles

654 Guided Discontinuation Versus Maintenance Treatment in Remitted First-Episode Psychosis: Relapse Rates and Functional Outcome. Lex Wunderink, Fokko J. Nienhuis, Sjoerd Sytema, Cees J. Slooff, Rikus Knegtering, and Durk Wiersma
[Abstract] [PDF]

662 Aripiprazole Effects in Patients With Acute Schizophrenia Experiencing Higher or Lower Agitation: A Post Hoc Analysis of 4 Randomized, Placebo-Controlled Clinical Trials. Stephen R. Marder, Britt West, Gina S. Lau, Joseph A. Pultz, Andrei Pikalov, Ronald N. Marcus, Rolando Gutierrez-Esteinou, and David T. Crandall
[Abstract] [PDF]

677 A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Desvenlafaxine Succinate in the Treatment of Major Depressive Disorder. Nicholas A. DeMartinis, Paul P. Yeung, Richard Entsuah, and Amy L. Manley
[Abstract] [PDF]

689 Decisional Capacity to Consent to Research Among Patients With Bipolar Disorder: Comparison With Schizophrenia Patients and Healthy Subjects. Barton W. Palmer, Laura B. Dunn, Colin A. Depp, Lisa T. Eyler, and Dilip V. Jeste
[Abstract] [PDF]

697 Impact of CYP1A2 and CYP2D6 Polymorphisms on Drug Metabolism and on Insulin and Lipid Elevations and Insulin Resistance in Clozapine-Treated Patients. Kristina I. Melkersson, M. Gabriella Scordo, Arzu Gunes, and Marja-Liisa Dahl
[Abstract] [PDF]

705 A Randomized, Double-Blind, Placebo-Controlled Trial of Modafinil for Negative Symptoms in Schizophrenia. Joseph M. Pierre, John H. Peloian, Donna A. Wirshing, William C. Wirshing, and Stephen R. Marder
[Abstract] [PDF]

711 Randomized, Double-Blind Comparison of Sertraline and Placebo for Posttraumatic Stress Disorder in a Department of Veterans Affairs Setting. Matthew J. Friedman, Charles R. Marmar, Dewleen G. Baker, Carolyn R. Sikes, and Gail M. Farfel
[Abstract] [PDF]

721 Risk Factors for Suicide Completion in Borderline Personality Disorder: A Case-Control Study of Cluster B Comorbidity and Impulsive Aggression. Alexander McGirr, Joel Paris, Alain Lesage, Johanne Renaud, and Gustavo Turecki
[Abstract] [PDF]

730 Randomized Controlled Trial of Cognitive Behavioral Social Skills Training for Older People With Schizophrenia: 12-Month Follow-Up. Eric Granholm, John R. McQuaid, Fauzia Simjee McClure, Peter C. Link, Dimitri Perivoliotis, Jennifer D. Gottlieb, Thomas L. Patterson, and Dilip V. Jeste
[Abstract] [PDF]

738 Natural Course of Bulimia Nervosa and of Eating Disorder Not Otherwise Specified: 5-Year Prospective Study of Remissions, Relapses, and the Effects of Personality Disorder Psychopathology. [CME] Carlos M. Grilo, Maria E. Pagano, Andrew E. Skodol, Charles A. Sanislow, Thomas H. McGlashan, John G. Gunderson, and Robert L. Stout
[Abstract] [PDF]

747 Prediction of Response to Paroxetine and Venlafaxine by Serotonin-Related Genes in Obsessive-Compulsive Disorder in a Randomized, Double-Blind Trial. Damiaan Denys, Filip Van Nieuwerburgh, Dieter Deforce, and Herman G. M. Westenberg
[Abstract] [PDF]

754 Disrupted Antioxidant Enzyme Activity and Elevated Lipid Peroxidation Products in Schizophrenic Patients With Tardive Dyskinesia. Xiang Yang Zhang, Yun Long Tan, Dong Feng Zhou, Lian Yuan Cao, Gui Ying Wu, Colin N. Haile, Therese A. Kosten, and Thomas R. Kosten
[Abstract] [PDF]

761 Duloxetine Treatment of Dysthymia and Double Depression: An Open-Label Trial. Lorrin M. Koran, Elias N. Aboujaoude, and Nona N. Gamel
[Abstract] [PDF]

Commentary

669 Exercise for Mood and Anxiety Disorders. [CME] Michael W. Otto, Timothy S. Church, Lynette L. Craft, Tracy L. Greer, Jasper A. J. Smits, and Madhukar H. Trivedi
[PDF]

Focus on Childhood and Adolescent Mental Health

766 "An Ounce of Prevention Is Worth a Pound of Cure." Melissa P. DelBello
[PDF]

767 Impact of Severity of Substance Use Disorder on Symptomatic and Functional Outcome in Young Individuals With First-Episode Psychosis. Darryl Wade, Susy Harrigan, Patrick D. McGorry, Philip M. Burgess, and Greg Whelan
[Abstract] [PDF]

775 Regular Daily Smoking Among 14-Year-Old Adolescents Increases the Subsequent Risk for Suicide: The Northern Finland 1966 Birth Cohort Study. Kaisa Riala, Antti Alaräisänen, Anja Taanila, Helinä Hakko, Markku Timonen, and Pirkko Räsänen
[Abstract] [PDF]

781 Double-Blind, Placebo-Controlled Trial of Divalproex Monotherapy in the Treatment of Symptomatic Youth at High Risk for Developing Bipolar Disorder. Robert L. Findling, Thomas W. Frazier, Eric A. Youngstrom, Nora K. McNamara, Robert J. Stansbrey, Barbara L. Gracious, Michael D. Reed, Christine A. Demeter, and Joseph R. Calabrese
[Abstract] [PDF]

789 A 12-Week Single-Blind Trial of Quetiapine for the Treatment of Mood Symptoms in Adolescents at High Risk for Developing Bipolar I Disorder. Melissa P. DelBello, Caleb M. Adler, Rachel M. Whitsel, Kevin E. Stanford, and Stephen M. Strakowski
[Abstract] [PDF]

ASCP Corner

796 Psychopharmacology in the Emergency Room. Michael D. Jibson
[PDF]

Letters To the Editor

798 Resolution of Late-Onset Hypomania After Repair of Carotid Artery Stenosis: A Case of Vascular Hypomania. Abigail L. Donovan and Oliver Freudenreich
[PDF]

798 Augmentation of Clozapine Treatment With Aripiprazole. Sabina Lim and Malcolm B. Bowers
[PDF]

799 What Do We Know About Insulin Resistance and Glucose Metabolism in Patients With Schizophrenia Treated With Antipsychotics? Jamie Karagianis, Vicki Poole Hoffmann, Virginia L. Stauffer, and Tamás Treuer
[PDF]

  • Replies by Belen Arranz and Luis San, and David C. Henderson

802 Decreased Lipoprotein Lipase as a Risk Factor for Atypical Neuroleptic-Induced Hypertriglyceridemia. Kenji Yamamoto, Masamichi Fukuda, Akiko Nogawa, Eri Takahashi, and Hitoshi Miyaoka
[PDF]

803 A Case Report of Reemergence of Antipsychotic-Induced Dyskinesia With Citalopram. Harpreet S. Duggal and Dattatreya N. Mendhekar
[PDF]

803 A Pilot Observational Crossover Study of QTc Interval Changes Associated With Switching Between Olanzapine and Risperidone. Chieh-Liang Huang, Kuan-Pin Su, Hsiu-Bao Hsu, and Carmine M. Pariante
[PDF]

805 Aripiprazole and Worsening of Psychosis: A Case Report. Niraj Ahuja and Adrian J. Lloyd
[PDF]

806 Correction. Endicott J, Russell JM, Raskin J, Detke MJ, Erickson J, Ball SG, Marciniak M, and Swindle RW. Duloxetine treatment for role functioning improvement in generalized anxiety disorder: three independent studies (J Clin Psychiatry 2007;68:518-524)
[PDF]

Book Reviews 807

Electronic CME Activities

Available through www.psychiatrist.com/toc

e12 Series Introduction and Cardiovascular Disease in Patients With Schizophrenia. John W. Newcomer and Charles H. Hennekens

e13 Evidence of Switching Antipsychotic Therapy to Improve Metabolic Disturbances. Peter J. Weiden and John W. Newcomer